Perspective Therapeutics (CATX) Loans - Net (2022)

Perspective Therapeutics (CATX) reported Loans - Net of $6.1 million for Q4 2022.

Perspective Therapeutics (CATX) Loans - Net (2022) Analysis & Trends

Perspective Therapeutics (CATX) has 1 years of Loans - Net data on file, last reported at $6.1 million in Q4 2022.

For the quarter ending Q4 2022, Loans - Net changed N/A year-over-year to $6.1 million; the trailing twelve-month figure through Dec 2022 stood at $6.1 million (changed N/A YoY), and the FY2022 full-year result was $6.1 million, changed N/A from the prior year.
Loans - Net steadied at $6.1 million in Q4 2022.
In the past five years, Loans - Net ranged from a high of $6.1 million in Q4 2022 to a low of $6.1 million in Q4 2022.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Loans - Net (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	-
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	-
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	-
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	-
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	-
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	-
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	-
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	-
10	Perspective Therapeutics	146.05 Mn	146.05 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2022	6.11 Mn
Dec 31, 2022	6.11 Mn